Advocacy and Legal Update 2024 – An Eventful Year for 340B and Insurance Reforms by the Artemis Policy Group The Hemophilia Alliance advocacy and legal agenda was jam packed in Read the full article…
Advocacy Update The 2024 Election & Potential Impacts on HTCs by the Artemis Policy Group With the exception of a handful of House races, the results of the 2024 election Read the full article…
Advocacy Update 340B Reform Legislation – Current Status and Predictions by Artemis Policy Group 2024 has been an active year for 340B Reform legislative proposals. As of now, there are Read the full article…
Advocacy and Legal Update A Flurry of Activity Related to HTCs and 340B Pre-Election by the Artemis Policy Group As Fall progresses, common wisdom in DC is to not anticipate Read the full article…
Advocacy and Legal Update Summer Regulations Impact on HTCs The Food and Drug Administration Finalizes Regulation of Laboratory Developed Tests by Issie Karan, Artemis Policy Group Earlier this year, the Read the full article…
Advocacy and Legal Update 340B Reform Bill Introduced in House by Johanna Gray, Artemis Policy Group In late May, Reps. Bucshon (R-IL), Carter (R-GA), and Harshbarger (R-TN) introduced the 340B Read the full article…
Advocacy and Legal Update New Research on 340B Program Spending Highlights Differences Among Covered Entities by Elizabeth ‘Issie’ Karan, Legal Counsel In a presentation at the 13th Annual Conference of Read the full article…
Advocacy and Legal Update Hill Day Alumni’s Comic Book, “What is Factor 8?”, Featured on the News by Elizabeth ‘Issie’ Karan, Legal Counsel Earlier this year, the Cordes Family participated Read the full article…
Advocacy and Legal Update by Elizabeth ‘Issie’ Karan, Legal Counsel OPA Releases Much Anticipated Alternative Dispute Resolution Rule for the 340B Program On April 18, 2024, the Health Resources and Read the full article…
Advocacy and Legal Update by Ellen Riker and Johanna Gray, Artemis Policy Group WE NEED YOU! Register for the Hemophilia Alliance Hill Day in April Please join us for the Read the full article…
